These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36109791)

  • 41. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural tannin extracts supplementation for COVID-19 patients (TanCOVID): a structured summary of a study protocol for a randomized controlled trial.
    Molino S; Pisarevsky A; Mingorance FL; Vega P; Stefanolo JP; Repetti J; Ludueña G; Pepa P; Olmos JI; Fermepin MR; Uehara T; Villapol S; Savidge T; Treangen T; Viciani E; Castagnetti A; Piskorz MM
    Trials; 2021 Apr; 22(1):310. PubMed ID: 33910614
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CO-Sprout-A Pilot Double-Blinded Placebo-Controlled Randomised Trial of Broccoli Sprout Powder Supplementation for Pregnant Women with COVID-19 on the Duration of COVID-19-Associated Symptoms: Study Protocol.
    Fields NJ; Palmer KR; Rolnik DL; Yo J; Nold MF; Giles ML; Krishnaswamy S; Serpa Neto A; Hodges RJ; Marshall SA
    Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical efficacy of iodine complex in SARS-CoV-2-infected patients with mild to moderate symptoms: study protocol for a randomized controlled trial.
    Ashraf S; Ashraf S; Ashraf M; Farooq I; Akmal R; Imran MA; Kalsoom L; Ashraf S; Rafique S; Ghufran M; Akram MK; Sohaib-Ur-Rehman ; Nadeem MF; Matti N; Siddiqui UN; Humayun A; Saboor QA; Ahmad A; Ashraf M; Izhar M;
    Trials; 2022 Jan; 23(1):58. PubMed ID: 35045888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
    Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
    Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re-analysis of randomized trial data.
    Hemilä H; Chalker E
    Pharmacol Res Perspect; 2021 Aug; 9(4):e00810. PubMed ID: 34128358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures.
    Schütz D; Conzelmann C; Fois G; Groß R; Weil T; Wettstein L; Stenger S; Zelikin A; Hoffmann TK; Frick M; Müller JA; Münch J
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L750-L756. PubMed ID: 33561380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early Negativization of SARS-CoV-2 Infection by Nasal Spray of Seawater plus Additives: The RENAISSANCE Open-Label Controlled Clinical Trial.
    Cegolon L; Mastrangelo G; Emanuelli E; Camerotto R; Spinato G; Frezza D
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432693
    [No Abstract]   [Full Text] [Related]  

  • 51. Review of the use of nasal and oral antiseptics during a global pandemic.
    Stathis C; Victoria N; Loomis K; Nguyen SA; Eggers M; Septimus E; Safdar N
    Future Microbiol; 2021 Jan; 16(2):119-130. PubMed ID: 33464122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients.
    Klussmann JP; Grosheva M; Meiser P; Lehmann C; Nagy E; Szijártó V; Nagy G; Konrat R; Flegel M; Holzer F; Groß D; Steinmetz C; Scherer B; Gruell H; Schlotz M; Klein F; de Aragão PA; Morr H; Al Saleh H; Bilstein A; Russo B; Müller-Scholtz S; Acikel C; Sahin H; Werkhäuser N; Allekotte S; Mösges R
    Sci Rep; 2023 Apr; 13(1):6839. PubMed ID: 37100830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Effect of Povidone-Iodine Nasal Spray on Nasopharyngeal SARS-CoV-2 Viral Load: A Randomized Control Trial.
    Zarabanda D; Vukkadala N; Phillips KM; Qian ZJ; Mfuh KO; Hatter MJ; Lee IT; Rao VK; Hwang PH; Domb G; Patel ZM; Pinsky BA; Nayak JV
    Laryngoscope; 2022 Nov; 132(11):2089-2095. PubMed ID: 34724213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seawater nasal wash to reduce symptom duration and viral load in COVID-19 and upper respiratory tract infections: a randomized controlled multicenter trial.
    de Gabory L; Vallet S; Naelten G; Raherison-Semjen C
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3625-3637. PubMed ID: 38376591
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formulation of a Composite Nasal Spray Enabling Enhanced Surface Coverage and Prophylaxis of SARS-COV-2.
    Moakes RJA; Davies SP; Stamataki Z; Grover LM
    Adv Mater; 2021 Jul; 33(26):e2008304. PubMed ID: 34060150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review.
    Frediansyah A
    Clin Epidemiol Glob Health; 2021; 12():100826. PubMed ID: 34222718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial.
    Tandon M; Wu W; Moore K; Winchester S; Tu YP; Miller C; Kodgule R; Pendse A; Rangwala S; Joshi S;
    Lancet Reg Health Southeast Asia; 2022 Aug; 3():100036. PubMed ID: 35784831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis.
    Graf C; Bernkop-Schnürch A; Egyed A; Koller C; Prieschl-Grassauer E; Morokutti-Kurz M
    Int J Gen Med; 2018; 11():275-283. PubMed ID: 30013382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protocol: carrageenan for the prevention of oral HPV infection - a feasibility randomised clinical trial.
    Alli BY; Madathil S; Tran SD; Nicolau B
    BMJ Open; 2023 Jul; 13(7):e074498. PubMed ID: 37500273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nasal spray of an IgM-like ACE2 fusion protein HH-120 prevents SARS-CoV-2 infection: Two investigator-initiated postexposure prophylaxis trials.
    Song R; Chen X; Li B; Ni J; Zhou Y; Zhang H; Liang X; Zou L; Liu J; Yang F; Li G; Guo X; Liu Z; Mao F; Lei C; Sui J; Li W; Jin R
    J Med Virol; 2023 Dec; 95(12):e29275. PubMed ID: 38054556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.